Case File
efta-efta00480388DOJ Data Set 9OtherFrom: Haydar Haba <
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00480388
Pages
3
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Haydar Haba <
To:
Cc: Paul Than
,
Masha
Prusakova
, Roman Glukhovsky
Subject: Re: Andra Info Submission to Jeffrey Epstein
Date: Mon, 20 Aug 2018 23:12:48 +0000
Please let Jeffery know we are sending traditional LP PPM sometime this week. So we can probably setup a
meeting sometime next week.
Regards
Haydar Haba. Managing Partner
Andra Capital
rn
e
www.andracapital.c
Andra Capital LLC acctpts no halnlity for any errors or omissions arising as a result of this transmission. This message, including attachments. is intended only for the use of the
individual or entity to whom it is addressed and may contain information that is privileged, confidential and exempt from disclosure under applicable law if
are nor the
intended addressee. you mart not use. ropy. disclose or take any action based on this message or any information herein. If you received this message in error. please immediately
notify us. Andra Capital and its affiliates reserve the right to archive, monitor and review all email. This message does not constitute an offer to sell or a solicitation of an offer to
buy any moat-lot Accordingly. no representation or warranty. expressed or otherwise. is made to. and no reliance should be placed on, the fairness. accuracy. completeness or
timeliness of the information contained here.
On Aug 20, 2018, at 4:09 PM,
Hello Paul. I will let Jeffrey know you are following up!
Sent from my iPhone
On Aug 20, 2018, at 6:51 PM, Paul Tuan
Hi =I
wrote:
wrote:
Hope you had a great weekend. I wanted to check in and see if Jeffrey had any questions regarding our
materials. Can we schedule a call with him this week to discuss this engagement in detail? Thank you in
advance for coordinating.
Best,
Paul
Paul Tuan, Managing Director
Andra Capital
www.andracapitalcom
EFTA00480388
Andra Capital LLC accepts no liaNlihrfor any errors or omissions arising as a result of this transmission. This message, including attachments, it intended only for the use of
the Individual or mil°, to whom it is addressed, and may contain information that is privileged confidential and exempt from disclosure under applicable law. !Lyda are not the
intended addressee. 'emu mutt not use, copj; disclose or take any action based on this message or any information herein. !Irma received this message in error. please
immediately not°, us. Andra Capital and lu affiliates reserve the right to archive. monitor and review all email. This message does not constitute an offer to sell or a
solicitation of an offer to lnty any seaniht Accordingly, no representation or warranty expressed or otherwise. is made to. and no reliance should be placed on, the fairness.
accuracy completeness or timeliness of the information contained here.
On Thu, Aug 9, 2018 at 3:28 PM, Haydar Haba <
wrote:
Thank you M.
Looking forward for his feedback.
Regards
Haydar Haba
On Aug 9, 2018, at 6:26 PM,
Hello Paul. Happy to pass along to Jeffrey! Thanks,
Sent from my iPhone
On Aug 9, 2018, at 6:23 PM, Paul Tuan <
wrote:
• wrote:
Hi
Thank you in advance for coordinating. Will you please forward this email to Jeffrey?
Hi Jeffrey,
Nice to meet you! Haydar really enjoyed meeting with you yesterday and speaks highly of
you. He asked that we provide you with some additional documentation regarding our
innovation-impact fund. I've attached our fund structure chart, PPM, white paper, and investor
deck for your reference.
Andra Capital is a late-stage technology growth fund. Investors may participate in our fund
through: (i) direct traditional LP interest; or (ii) tokenized LP interest (blockchain smart
contracts). Below are some highlights of the fund:
• 30%+ target IRR returns, comparable with top-tier VCs
• Portfolio of the fastest growing technology pre-IPO companies
• World-class service providers include: lead counsel (DLA Piper); auditor (Deloitte);
compliance and valuation (Duff & Phelps); fund admin (Apex)
• News Releases: Business Wire Fortune Ledger Show Venture Beat Fintek Bitcoin
Exchange
Our fund's innovative Silicon Valley Coin (SVC) provides liquidity on digital exchanges and
access for global investors:
• Ability to convert direct LP interest into SVCs
• Asset-backed, regulatory compliant, and tradable security token feature
• Option to cash out and realize investment returns without the typical waiting period of 8-
12 years
I suggest that we schedule a call next week to discuss in detail once you've had a chance to
review the documents. Given your successful background in finance, we would be happy to
offer you a GP-purchase proposal for an opportunity to own an equity stake in our entire
EFTA00480389
infrastructure. I've attached the GP model demonstrating the economics for your review. I look
forward to speaking to you.
Best,
Paul
2
Paul Tuan, Managing Director
Andra Capital
e
winv.andracapital.com
Andra Capital LLC acrepts no liability for any errors or omissions arising as a result of this transmission. This message, including attachments. is intended only for
the use of the individual or entity to Whom is is addressed, and may contain information that is privileged. confidential and exempt from disclosure under applicable
law. lf you are not the intended addressee. you must not use, copy. disclose or take any action based on this message or any information herein. if
received this
message in error. please immediately notify us. Andra Capital and its affiliates reserve the right to archive. monitor and review all email. This message does not
constitute an offer to sell or a solicitation of an offer to bay any security. Accordingly. no representation or warranty. expressed or otherwise. is made to. and no
reliance should be placed on, the fairness. accuracy. completeness or timeliness of the information contained here.
<Andra Fund - White Paper 7.16.2018 vfinal.pdf>
<Andra - Private Placement Offering Memorandum (Final).pdf>
<Andra Capital Investor Deck Final 8.8.2018.pdf>
<Andra Capital - Modified Structure Chart 8-7a.pdf>
<Andra GP Purchase Proforma 8.8.2018.xlsx>
EFTA00480390
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
winv.andracapital.comWire Ref
Wire FortuneWire Ref
referenceRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.